Efficacy and safety of tamsulosin for benign prostatic hyperplasia: clinical experience in the primary care setting.
Flannery, Michael T; Ramsdell, Joe; Ranhosky, Alan; Davidai, Giora; Ruoff, Gary.
Curr Med Res Opin
; 22(4): 721-30, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16684433
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.
Efficacy and safety of tamsulosin in the treatment of benign prostatic hyperplasia.
[The study of renal safety in elderly patients with benign prostatic hyperplasia treated with α receptor blockers].
Efficacy and Safety of Medium-to-long-term Use of Tolterodine Extended Release with or without Tamsulosin in Patients with Benign Prostate Hyperplasia and Larger Prostate Size: A Double-blind, Placebo-controlled, Randomized Clinical Trial.
The role of alpha blockers prior to removal of urethral catheter for acute urinary retention in men.
Alpha blockers prior to removal of a catheter for acute urinary retention in adult men.
[CATARACT SURGERY COMPLICATIONS IN MALES TREATED WITH ALPHA-1 ANTAGONISTS FOR BENIGN PROSTATIC HYPERPLASIA].
Tamsulosin modified release and oral controlled absorption system in the management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
[A randomized controlled study comparing clinical effects of naftopidil and tamsulosin on benign prostatic hyperplasia].
α-Blocker and Risk of Dementia in Patients with Benign Prostatic Hyperplasia: A Nationwide Population Based Study Using the National Health Insurance Service Database.